We Can't Go on Meeting Like This

Click for larger version (14K) We surveyed our readers to find out if they attend scientific meetings and why they do. Of the 282 who responded, 81% travel to one or more scientific meetings every year. An inveterate 13% go to more than three meetings per year. Readers ranked the importance of various reasons for attending conferences on a 1-to-5 scale, with 5 considered very important. Three motivations stand out: Attending formal lectures and sessions (4.4), meeting informally with collea

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

We surveyed our readers to find out if they attend scientific meetings and why they do. Of the 282 who responded, 81% travel to one or more scientific meetings every year. An inveterate 13% go to more than three meetings per year.

Readers ranked the importance of various reasons for attending conferences on a 1-to-5 scale, with 5 considered very important. Three motivations stand out: Attending formal lectures and sessions (4.4), meeting informally with colleagues (4.3), and visiting poster sessions (4.1). Visiting the commercial exhibit (3.0) came next. Sightseeing (2.9), attending social functions (2.9), and seeking employment opportunities (2.4) were the lowest-ranked reasons.

"We who are supported by federal funds should not use scientific conferences as a front for a vacation or a seven-day binge of overindulgence in free beer," says one reader. Why not, says another: "We only have an allowance to go away once during our PhD study, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies